CNADF.US CanadaBis Capital Inc.

Healthcare Pharmaceuticals USA Stocks
0.0022 USD
Close of Nov 13, 2026
0.0021 0.0625
Market cap
USD 310K
P/E
-
P/B
0.06x
ROE
-6.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Oct 2025.

Is CNADF.US undervalued?

Graham number

The Graham number of CanadaBis Capital Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CanadaBis Capital Inc. fundamental analysis

No fundamental analysis for CanadaBis Capital Inc. yet.

CanadaBis Capital Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CanadaBis Capital Inc.

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the production and wholesale distribution of cannabis extract products through the Company's manufacturing facilities to licensed distributors and cannab…

Full company profile